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Brain natriuretic peptide (BNP) exerts its functions through NP receptors. Recently, BNP
has been shown to be involved in a wide range of functions. Previous studies reported
BNP expression in the sensory afferent fibers in the dorsal horn (DH) of the spinal cord.
However, BNP expression and function in the neurons of the central nervous system
are still controversial. Therefore, in this study, we investigated BNP expression in the
rat spinal cord in detail using reverse transcription-polymerase chain reaction (RT-PCR)
and immunohistochemistry. RT-PCR analysis showed that BNP mRNA was present in
the spinal cord and dorsal root ganglion (DRG). BNP immunoreactivity was observed in
different structures of the spinal cord, including the neuronal cell bodies and neuronal
processes. BNP immunoreactivity was observed in the DH of the spinal cord and in the
neurons of the intermediate column (IC) and ventral horn (VH). Double-immunolabeling
showed a high level of BNP expression in the afferent fibers (laminae I–II) labeled
with calcitonin gene-related peptide (CGRP), suggesting BNP involvement in sensory
function. In addition, BNP was co-localized with CGRP and choline acetyltransferase
(ChAT) in the motor neurons of the VH. Together, these results indicate that BNP is
expressed in sensory and motor systems of the spinal cord, suggesting its involvement
in several biological actions on sensory and motor neurons via its binding to NP
receptor-A (NPR-A) and/or NP receptor-B (NPR-B) at the spinal cord level.
Keywords: brain natriuretic peptide, CGRP, ChAT, co-localization, immunohistochemistry, sensory, motor
neurons
INTRODUCTION
The natriuretic peptide (NP) family consists of atrial NP (ANP), brain NP (BNP) and C-type
NP (CNP; Potter et al., 2009). Although BNP was originally discovered in the porcine brain, it
is predominately produced from by the heart ventricles (Minamino et al., 1988; Abdelalim et al.,
2006a,b). The physiological functions of BNP are induced by its binding to NP receptor-A (NPR-A;
Misono et al., 2011). Some studies also suggested that BNP could perform certain functions
though it’s binding to NP receptor type B (NPR-B; Suga et al., 1992; Abdelalim and Tooyama,
2009). In response to BNP binding, both guanylyl cyclase receptors produce intracellular cyclic
guanosine monophosphate (cGMP; Garbers, 1992). Several studies showed that BNP plays an
essential role in cardiovascular homeostasis (Woodard and Rosado, 2007; Potter et al., 2009).
However, other reports demonstrated that BNP and its receptors are expressed in several cell
types that are not related to cardiovascular control, indicating BNP involvement in several functions
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(Cameron et al., 1996; Suda et al., 1998; Abdelalim et al., 2007,
2008a,b, 2013; Cao and Yang, 2008; Abdelalim and Tooyama,
2009, 2011a,b).
The expression of NPs was previously detected in the brain
and spinal cord of several animals (Zamir et al., 1986; Morii et al.,
1987; Ueda et al., 1988; Totsune et al., 1994; Cameron et al.,
1996). ANP in the brain is expressed in sensory fibers innervating
laminae I–II (Saper et al., 1989). In the spinal cord, ANP and BNP
proteins have been found in the fibers of laminae I–II (Kawata
et al., 1989; Nohr et al., 1989; Saper et al., 1989). Interestingly,
previous reports showed that there are no NP-immunoreactive
cell bodies in the spinal cord, suggesting that the immunoreactive
fibers might originate from the hypothalamus (Cechetto and
Saper, 1988; Nohr et al., 1989). However, our previous study on
monkey brain did not detect BNP mRNA in the neurons of the
hypothalamus (Abdelalim et al., 2006a). An overview of these
findings indicates that, although some studies demonstrated
the expression of NPs in the central nervous system, detailed
information on the distribution of BNP immunoreactivity in
different structures of the spinal cord is lacking. Therefore, in this
study, we investigated the distribution of BNP immunoreactivity
in different regions of the rat spinal cord. Furthermore, we
investigated BNP co-localization with calcitonin gene-related
peptide (CGRP) and choline acetyltransferase (ChAT) proteins
in sensory and motor systems of the spinal cord.
MATERIALS AND METHODS
Animals and Tissue Preparation
All experimental procedures were approved by the Institutional
Animal Care and Use Committee of Shiga University of
Medicine, and were designed to minimize the number of animals
and their suffering in accordance with the 1996 NIH Guide for
the Care and Use of Laboratory Animals.
Nine adult male Wistar rats (Clea Japan, Tokyo, Japan)
weighing 200–300 g were used. They were deeply anesthetized
by an intraperitoneal injection of sodium pentobarbital
(150mg/kg), and transcardially perfused with 10mMphosphate-
buffered saline (PBS, pH 7.4) at 20◦C. For reverse transcription-
polymerase chain reaction (RT-PCR) and Western blot analyses,
spinal cord segments and dorsal root ganglion (DRG) samples
were removed and stored at −80◦C. For immunohistochemical
studies, rats were similarly anesthetized, perfused transcardially
with PBS, and further perfused with an ice-cold fixative of 4%
paraformaldehyde in 0.1 M phosphate buffer (pH 7.4). Spinal
cord segments were collected and post-fixed by immersion for
24 h in the same fixative at 4◦C. After cryoprotection for 4 days in
phosphate buffer containing 15% sucrose at 4◦C, 20 µm sections
were cut in a cryostat. These sections were collected and stored
in 0.1 M PBS containing 0.3% Triton X-100 (PBST) at 4◦C.
Reverse Transcription-Polymerase Chain
Reaction (RT-PCR)
Total RNA was extracted from DRG and spinal cord samples
using a Fastpure RNA kit (Takara Bio, Otsu, Japan) and treated
with DNAse (Turbo DNAse, Ambion, Austin, TX, USA) prior
to reverse transcription. One microgram of total RNA was
reverse-transcribed into cDNA using SuperScript III (Thermo
Fisher Scientific Inc., Waltham, MA, USA) and an oligo dT
adapter primer. Specific BNP cDNA was amplified by PCR using
Ex Taq HS DNA polymerase (Takara Bio) and the following
rat BNP primers: 5′-CAGAAGGTGCTGCCCCAGATG-3′
(sense) and 5′-GACTGCGCCGATCCGGTC-3′ (antisense).
The amplification profile consisted of an initial step of
denaturation at 95◦C for 1 min, 36 cycles of 10 s at
98◦C, 30 s at 55◦C and 1 min at 72◦C, followed by final
extension at 72◦C for 8 min. The PCR products were
electrophoresed on a 2% agarose gel and stained with ethidium
bromide.
Western Blot Analysis
Spinal cord samples were homogenized in ice-cold RIPA
buffer containing protease inhibitors. The homogenates were
centrifuged at 15,000 rpm for 20 min at 4◦C, and then
the supernatants were collected. Protein concentrations were
detected using the Bio-Rad Protein Assay kit (Bio-Rad, Hercules,
CA, USA). Protein samples (29.4 µg) were electrophoresed
on 15% ready-to-use PAGE (WAKO, Japan) and transferred
onto PVDF membranes. The membranes were incubated in
20% reagent N102 (NOF Corp., Tokyo, Japan) in TBS for
1 h at room temperature to block non-specific protein binding
sites, then incubated overnight at 4◦C with a rabbit polyclonal
antibody BNP (Millipore, AB1549), at a dilution of 1:2000 in TBS
containing 0.1% Tween-20 (TBST) or with normal rabbit serum
(1:2000) in TBST as control. The blots were washed three times
for 20 min each with TBST, and then incubated for 1 h at
room temperature with peroxidase-conjugated goat anti-rabbit
IgG (1:25,000; Jackson ImmunoResearch, Baltimore, PA, USA).
After three washes with TBST, the blots were developed using
Chemi-lumi One Super (Nacalai, Japan), and visualized using a
LuminoImager LAS3000 (FujiFilm, Tokyo, Japan).
Immunohistochemistry
Serial cryostat sections (20 µm) were floated in 0.1 M PBST
(pH 7.4) for 4 days at 4◦C and treated in a free-floating state.
Endogenous peroxidase activity was blocked by incubating the
sections in 0.5% H2O2 in PBST for 30 min. After washing the
sections three times (10 min each) with PBST, they were blocked
in 5% bovine serum albumin (BSA) for 2 h at room temperature.
After blocking, they were incubated at 4◦C for 3 days with a rabbit
polyclonal antibody against rat BNP (1:4000 dilution; Millipore,
Temecula, CA, USA). The primary antibody was diluted in
2% BSA in PBST. After the sections had been rinsed three
times with PBST (10 min each time), they were incubated for
1 h at room temperature with biotinylated goat anti-rabbit IgG
(1:3000 dilution; Vector Laboratories, Burlingame, CA, USA)
before being rinsed another three times with PBST. The sections
were finally incubated for 1 h at room temperature with an
avidin-biotin-peroxidase complex (1:4000 dilution; ABC Elite;
Vector Laboratories, Burlingame, CA, USA) and the peroxidase-
labeled sections were developed in 0.02% 3,3-diamine-benzidine
tetrahydrochloride with 0.07% nickel ammonium sulfate in
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50 mM Tris-HCl (pH 7.6), with 0.005% H2O2. Negative control
sections were subjected to the same procedures without primary
antibody.
Double-Label Immunofluorescence
Free-floating sections of the spinal cord were blocked for 1 h at
room temperature with 5% BSA in PBST to block non-specific
binding, then incubated for 48 h at 4◦C with a mixture of
rabbit polyclonal antibody against rat BNP (diluted 1:2000;
Millipore) and either guinea-pig polyclonal CGRP antibody
(1:200; T-5053, Peninsula Lab, San Carlos, CA, USA) or goat
anti-ChAT antibody (diluted 1:500; Millipore). After three rinses
with PBST, sections were incubated for 3 h at room temperature
with the appropriate secondary antibodies. The secondary
antibodies were Alexa Fluor 555-conjugated anti-rabbit IgG,
Alexa Fluor 488-conjugated anti-guinea pig IgG, or Alexa Fluor
488-conjugated anti-goat IgG (diluted 1:500, Thermo Fisher
Scientific Inc., Waltham, MA, USA). Negative control sections
were subjected to the same procedures without primary antibody.
After three washes with PBST, the sections were mounted on
gelatin-coated glass slides and examined using a confocal laser-
scanning microscope (LSM 510 META, Carl Zeiss, Heidelberg,
Germany).
Image Acquisition and Data Analysis
The major regions of the spinal cord were identified according to
the rat brain atlas (Paxinos andWatson, 2006). Images of selected
sections were captured and organized into photographic panels.
To improve the visualization of the results, only the contrast and
brightness of the images were adjusted using Adobe Photoshop,
without any further manipulation of the images.
RESULTS
Specificity of the BNP Antibody
In this study, we used a primary antibody against rat BNP
to examine BNP immunoreactivity in the spinal cord. This
antibody was previously characterized (Abdelalim and Tooyama,
2009). In our previous study, we confirmed the specificity of
this antibody using Western blotting, where it recognized a
single band for BNP in rodent cells (Abdelalim and Tooyama,
2009). Furthermore, in the current study we performed Western
blotting to confirm the specificity on rat spinal cord samples. A
specific band was detected at approximately 33 kDa in the spinal
cord samples, corresponding to BNP protein (Figure 1B). It is
known that Western blotting is effective for validating antibody
specificity (Burry, 2000) and thus the antibody used in this study
can be considered to recognize rat BNP protein specifically.
Expression of BNP mRNA in the Rat Spinal
Cord and DRG
RT-PCR was used to examine the expression of BNP mRNA
in the spinal cord and DRG of rat. This analysis showed a
single band for BNP at the expected size (321 bp) in the
DRG and spinal cord (Figure 1). Here we included the DRG
in the examination because DRG neurons are known to send
FIGURE 1 | mRNA and protein expression levels of brain natriuretic
peptide (BNP) in the spinal cord. (A) RT-PCR analysis of BNP expression in
DRG and spinal cord. −RT, samples without reverse transcription. BNP band
appeared at the expected size (321 bp). (B) Western blot analysis was
performed using a polyclonal antibody raised against BNP. The antibody
recognized a single band at approximately 33 kDa in the spinal cord.
projections to the dorsal horn (DH) of the spinal cord, which
showed BNP immunoreactivity in the current study.
Distribution of BNP Immunoreactivity in
the Rat Spinal Cord
Immunohistochemical analysis revealed BNP immunoreactivity
in different regions of the spinal cord (cervical, thoracic,
lumbar and sacral) in neuronal cell bodies and nerve fibers
(Figure 2). In the negative control sections, no immunoreactivity
was observed (data not shown). In the cervical spinal cord
segments, BNP-immunoreactive dots were detected throughout
the laminae in the gray matter (Figures 2A–C). In the DH,
high-intensity of BNP-immunoreactive fibers was noted in
the DH (Figures 2A,B). In addition, the immunoreactive
dots were evident near the spinal canal (Figures 2A,C).
The BNP-immunoreactive cell bodies were detected in the
cervical segments and continued throughout the spinal cord
(Figures 2A–I). In the DH, BNP immunoreactivity was also seen
in nerve fibers (Figures 2D,F). BNP-immunoreactive neurons
were clearly observed in the intermediate column (IC) and the
ventral horn (VH) of the spinal cord (Figures 2A,C–I). In the
VH, strong BNP immunoreactivity was seen in the perikarya and
dendrites of the multipolar neurons, indicating its localization in
the motor spinal neurons (Figures 2C,E,G,I).
Double-Label Immunostaining
To investigate whether BNP is co-localized with CGRP in
sensory and motor systems in the spinal cord, we performed a
confocal microscopic analysis of the rat spinal cord sections to
recognize CGRP and BNP co-localization. It has been shown that
CGRP is expressed in the afferent fibers of laminae I–II of the
DH (Eftekhari and Edvinsson, 2011). Double-immunolabeling
of BNP and CGRP showed that BNP immunoreactivity was
co-localized with CGRP in the DH of the spinal cord, indicating
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FIGURE 2 | Localization of BNP protein in rat spinal cord. Left panels, line drawings for all segments presented in the figure (C3, C5, T3 and L5) based on the
rat brain atlas (Paxinos and Watson, 2006). (A) BNP immunoreactivity in C3 spinal segment. Note that BNP immunoreactivity was distributed throughout the gray
matter. (B) High intensity of BNP-immunoreactive fibers in the dorsal horn (DH) of C3. (C) BNP-immunoreactive neurons in the ventral horn (VH). (D) BNP
immunoreactivity in a caudal segment of the cervical spinal cord (C5). The immunoreactivity was seen in the DH, intermediate column (IC) and VH. (E) A
high-magnification image shows BNP immunoreactivity in the perikarya and neuronal processes (arrowheads) in the VH. (F) BNP immunoreactivity in a thoracic
segment of the spinal cord (T3). The immunoreactivity was seen in the DH, IC and VH. (G) A high-magnification image shows BNP immunoreactivity in the perikarya
and neuronal processes (arrowheads) in the VH. (H) BNP immunoreactivity in a lumber segment of the spinal cord (L5). The immunoreactivity was seen in the DH, IC
and VH. (I) A high-magnification image shows BNP immunoreactivity in the perikarya and neuronal processes (arrowheads) in the VH. Scale bars in (A–I) = 100 µm.
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FIGURE 3 | Immunofluorescence confocal photomicrographs, showing the co-localization of BNP and calcitonin gene-related peptide (CGRP) in rat
spinal cord. Spinal cord sections were labeled for BNP (red) and CGRP (green). (A) BNP immunoreactivity in the DH of the spinal cord. (B) CGRP-immunoreactive
fibers in laminae I–II. (C) Merged images show the co-localization of BNP and CGRP in superficial laminae I–II. (D) A low-magnification image shows BNP
immunoreactivity in the VH. (E) A low-magnification image shows CGRP immunoreactivity in the VH. (F) Merged images the co-localization of BNP and CGRP in the
VH. (G) A high-magnification image shows BNP-immunoreactive neurons in the VH. (H) A high-magnification image shows CGRP-immunoreactive motor neurons in
the VH. (I) Merged images show the co-localization of BNP and CGRP in the VH motor neurons. Scale bars in (A–C) and (G–I) = 100 µm and in (D–F) = 50 µm.
BNP expression in laminae I–II (Figures 3A–C). Furthermore, in
the VH, BNP was co-localized with CGRP in the perikarya of the
motor neurons (Figures 3D–I).
Furthermore, to examine whether spinal motor (ChAT-
positive) neurons express BNP, we performed a laser confocal
microscopic analysis of the rat spinal cord to recognize
BNP and ChAT co-localization. It is known that ChAT is
a marker for motor neurons, which are present in the VH
of the spinal cord. BNP immunoreactivity was co-localized
with ChAT-positive neurons in the VH of the spinal cord,
indicating BNP expression in the rat spinal motor neurons
(Figures 4A–F).
DISCUSSION
In the current study, we have revealed the detailed distribution
of BNP immunoreactivity in the rat spinal cord. We have also
reported for the first time that BNP protein is co-localized with
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FIGURE 4 | Immunofluorescence confocal photomicrographs, showing the localization of BNP (red) in motor neurons (green) of the rat spinal cord.
BNP-labeled cells in the VH (A). (B) Choline acetyltransferase (ChAT)-labeled cells in the VH. (C) Merged image shows the co-localization of BNP and ChAT in the
motor neurons. (D–F) A higher-magnification image shows the co-localization of BNP and ChAT in the motor neurons (arrowheads). Scale bars in (A–C) = 100 µm
and in (D–F) = 50 µm.
CGRP and ChAT proteins in the sensory and motor systems of
the spinal cord.
Previous studies illustrated the localization of BNP in the
spinal cord in the fibers of laminae I–II (Kawata et al., 1989;
Saper et al., 1989; Zhang et al., 2010). Earlier reports showed that
there are no NP-immunoreactive perikarya in the spinal cord
and suggested that the immunoreactive fibers may originate from
the hypothalamus (Cechetto and Saper, 1988; Nohr et al., 1989).
However, our recent study did not detect BNP immunoreactivity
in the neurons of the monkey hypothalamus (Abdelalim et al.,
2006a). BNP expression in the spinal cord neurons and its
function remain controversial. Thus, to provide evidence for
a putative role of BNP in the spinal cord, we used a specific
antibody to investigate the distribution of BNP immunoreactivity
in different regions of the rat spinal cord and its co-localization
with ChAT and CGRP proteins. In the spinal cord, we detected
BNP immunoreactivity in the neuronal cell bodies in the IC and
VH throughout the spinal cord, suggesting its expression in the
interneurons and motor neurons.
Localization of BNP in Sensory Afferent
Fibers of the Dorsal Horn
In the current study, we detected BNP immunoreactivity in the
DH of the spinal cord. Furthermore, a double-immunostaining
experiment showed that BNP protein is co-localized with CGRP
protein in the DH of the spinal cord. CGRP is released from
primary afferent fibers that convey nociceptive information in
the spinal cord and plays a crucial role in pain sensitivity
(Gangadharan and Kuner, 2013). The expression profile of
BNP with CGRP in the DH of the spinal cord suggests
that BNP is expressed in the primary afferent terminals of
nociceptive DRGneurons. This was confirmed in this study using
RT-PCR, where we found that BNP mRNA is also expressed
in rat DRG.
Our results agree with earlier studies, in which BNP
immunoreactivity was detected in laminae I–II of rat and pig
(Kawata et al., 1989; Saper et al., 1989). However, a recent study
was able to detect BNP protein in the spinal DH using Western
blotting, but could not detect BNP immunoreactivity in the
afferent fibers using immunohistochemistry (Zhang et al., 2010).
These variations are due to technical differences. In our study, we
used very sensitive protocols to detect BNP immunoreactivity.
As described above, the rat tissues were fixed using a perfusion
system and the immunohistochemical procedure was performed
using a free-floating technique, which is more sensitive than
other immunohistochemical techniques.
BNP and its receptors (NPR-A and NPR-B) are expressed in
rat DRG (Zhang et al., 2010; Abdelalim et al., 2013) and it has
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been found that their expressions are increased in response to
pain induction (Zhang et al., 2010). The BNP protein has been
found in CGRP-and isolectin B4 (IB4)-positive DRG neurons
(Zhang et al., 2010). Interestingly, our recent study showed the
co-localization of NPR-B with CGRP in the same DRG neurons
and in the DH of the spinal cord (Abdelalim et al., 2013). It
is known that CGRP is expressed in DRG small neurons and
afferent fibers in laminae I–II of the spinal cord (Gibson et al.,
1984; Schaible, 1996). After acute pain induction in animal
models, CGRP level is elevated in the DRG and DH of the spinal
cord (Traub et al., 1990; Zhang et al., 1993). Transection of
the DH causes a dramatic decrease of the CGRP expression in
the laminae I–II in the DH (Fernandez et al., 2003). However,
brachial plexus injury leads to an increase in the expression of
CGRP in the DH (Chen et al., 2010). These findings indicate the
essential role of CGRP in the pain pathway and its level is affected
by the nature and type of the nerve injury (Bergman et al., 1996;
Li et al., 2004). Taken together, these findings suggest that BNP in
the DRG and the spinal cordmay be involved in pain modulation
through NPR-A and/or NPR-B receptors.
Localization of BNP in Spinal Cord Motor
Neurons
The current study is the first to examine the relationship between
BNP and motor neurons in the spinal cord. We found that BNP
was co-localized with CGRP in the multipolar neurons in the
VH. Our results are consistent with those of the previous studies,
which showed that the CGRP is expressed in the motor neuron
in the ventral of the spinal cord (Chen et al., 2010; McCoy et al.,
2012; Cui et al., 2015; Kim et al., 2016), where it is co-localized
with ChAT (Zheng et al., 2008). CGRP plays different roles based
on its localization. It has been reported that the expression level
of CGRP in the motor neurons changes after nerve injury and
these changes depend on the age of the animal and the type of the
injury. In the spinal cord, CGRP immunoreactivity is temporarily
elevated in laminae I–IV of the DH andmotor neurons of the VH
after suffering a sciatic nerve injury (Zheng et al., 2008). Another
study reported that sciatic nerve injury leads to down-regulation
of CGRP transcripts in the motor neurons of the VH in the first
week after birth and starts to be unregulated 12 days after birth
(Tonra and Mendell, 1998). Recently, it has also been suggested
that CGRP expression in the spinal cord is involved in the growth
of sensory and motor axons (Kim et al., 2016). Taken together,
these findings suggest that BNP might play a role in repair
mechanisms following nerve injuries.
We also found that BNP was co-localized with ChAT-positive
neurons, indicating its localization in the spinal motor
neurons in the VH. Our previous report demonstrated the
co-localization of NPR receptors (NPR-A, NPR-B and NPR-
C) with ChAT-positive neurons in the central nervous system
(Abdelalim et al., 2007, 2008a,b; Abdelalim and Tooyama, 2010).
The relationship between NPs and cholinergic (ChAT-positive)
neurons has been previously reported. It has been found that
stimulation of cholinergic neurons in the anteroventral third
ventricle leads to induction of ANP expression hypothalamus
(Antunes-Rodrigues et al., 1996). These findings suggest that
NPs may play an essential role in mediating motor function
by binding to their receptors. These findings also indicate
that BNP may be involved in specific motor functions in the
spinal cord.
CONCLUSION
In the current study, we detected BNP immunoreactivity
in the afferent fibers in the DH of the spinal cord, as
previously reported, and showed that this immunoreactivity
was co-localized with CGRP protein, suggesting BNP
involvement in pain mechanisms. Interestingly, we detected
BNP immunoreactivity in the neurons of the IC and VH of
the spinal cord. Using double immunostaining, we showed
that BNP is co-localized with CGRP and ChAT in the VH of
the spinal cord, indicating its expression in motor neurons.
The main findings of this report are as follows: (1) This is the
first report to confirm the localization of BNP in the spinal
neurons, particularly motor neurons. (2) This is the first time the
relationship between BNP and CGRP or ChAT in the spinal cord
has been studied. Taking these findings together with previous
studies, BNP expression in the primary sensory afferents and
motor neurons suggests its involvement in the pain pathway and
motor function through its binding to NPR-A and/or NPR-B
receptors. Further functional studies are needed to clarify the
exact role of BNP in the sensory and motor systems of the
spinal cord.
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